Skip to main content
Premium Trial:

Request an Annual Quote

Genomic Solutions to Acquire GeneMachines for $8.3M

NEW YORK, March 3 - Genomic Solutions, a wholly owned subsidiary of Harvard Bioscience, said today that it plans to acquire genomic tool company GeneMachines for around $8.3 million in cash.


The acquisition is expected to close in mid March, subject to the approval of GeneMachines' shareholders. According to Harvard Bioscience, enough GeneMachines shareholders necessary to approve the transaction have already entered agreed to vote in favor of the acquisition.


GeneMachines develops and distributes high-throughput instrumentation for DNA and protein microarray production, nucleic acid sample preparation, and DNA synthesis.


Click here for further information.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.